Literature DB >> 22038852

Sparsomycin-linezolid conjugates can promote ribosomal translocation.

Shibo Li1, Xiaofeng Cheng, Yonghang Zhou, Zhen Xi.   

Abstract

Sparsomycin is an antibiotic that targets the peptidyl transferase center of the ribosome and has the ability to promote ribosomal translocation in the absence of EF-G and GTP. Here we show that changes in the configurations at the two chiral centers of sparsomycin, especially at the chiral carbon, can greatly affect its capability to promote ribosomal translocation. More importantly, the incorporation of the pseudo-uracil moiety of sparsomycin into linezolid through a covalent linkage conferred on linezolid derivatives the ability to promote translocation, thus indicating the importance of interactions between this pseudo-uracil moiety, rRNA, and tRNA for promoting translocation. In addition, these translocation promoters can also effectively inhibit spontaneous reverse translocation; this suggests that they might promote forward translocation by trapping the ribosome in the post-translocation state and shifting the equilibrium between the pre- and post-translocation ribosome in the forward direction.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22038852     DOI: 10.1002/cbic.201100508

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  3 in total

Review 1.  Ribosome-targeting antibiotics and mechanisms of bacterial resistance.

Authors:  Daniel N Wilson
Journal:  Nat Rev Microbiol       Date:  2014-01       Impact factor: 60.633

2.  Antibiotics that bind to the A site of the large ribosomal subunit can induce mRNA translocation.

Authors:  Dmitri N Ermolenko; Peter V Cornish; Taekjip Ha; Harry F Noller
Journal:  RNA       Date:  2012-12-17       Impact factor: 4.942

3.  Structural basis of translation inhibition by cadazolid, a novel quinoxolidinone antibiotic.

Authors:  Alain Scaiola; Marc Leibundgut; Daniel Boehringer; Patrick Caspers; Daniel Bur; Hans H Locher; Georg Rueedi; Daniel Ritz
Journal:  Sci Rep       Date:  2019-04-04       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.